Oxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma(MZL)

Clinical trial NCT01068392 · COMPLETED

Trial details

NCT number: NCT01068392
Sponsor: Dong-A University Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

B-cell Lymphomas

Start date: 2009-10-01
Primary completion: 2013-09-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.